共 150 条
[41]
Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients:: 6-year follow-up results of the French Adjuvant Study Group 08 Trial
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2004, 22 (23)
:4674-4682
[45]
FERLAY J, 2004, 5 IARC
[46]
POSTOPERATIVE CHEMOTHERAPY AND TAMOXIFEN COMPARED WITH TAMOXIFEN ALONE IN THE TREATMENT OF POSITIVE-NODE BREAST-CANCER PATIENTS AGED 50 YEARS AND OLDER WITH TUMORS RESPONSIVE TO TAMOXIFEN - RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT-B-16
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1990, 8 (06)
:1005-1018
[49]
Gage I, 1996, CANCER-AM CANCER SOC, V78, P1921, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1921::AID-CNCR12>3.0.CO
[50]
2-#